Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 185 | 160 | 274 | 235 | 0 |
| Gross Profit | 185 | 160 | 274 | 235 | N/A |
| Operating Expenses | 3,104 | 3,861 | 3,651 | 4,061 | 2,443 |
| Operating Income | -2,920 | -3,701 | -3,377 | -3,826 | -2,443 |
| Other Income | 0 | 0 | 0 | 3 | 0 |
| Pre-tax Income | -2,920 | -3,701 | -3,377 | -3,823 | -2,442 |
| Net Income Continuous | -2,920 | -3,701 | -3,377 | -3,823 | -2,442 |
| Net Income | $-2,920 | $-3,701 | $-3,377 | $-3,823 | $-2,442 |
| EPS Basic Total Ops | -1,511.40 | -2,051.18 | -1,943.22 | -2,483.01 | -1,673.33 |
| EPS Basic Continuous Ops | -1,507.25 | -2,042.75 | -1,966.20 | -2,464.18 | -1,680.12 |
| EPS Diluted Total Ops | -1,511.40 | -2,051.18 | -1,943.22 | -2,483.01 | -1,673.33 |
| EPS Diluted Continuous Ops | -1,507.25 | -2,042.75 | -1,966.20 | -2,464.18 | -1,680.12 |
| EBITDA(a) | $-2,915 | $-3,697 | $-3,377 | $-3,826 | $-2,443 |